Finance

The Alzheimer's Disease Data Initiative is accepting applications for a $1 million first prize for agentic AI Alzheimer's research.

The company plans to launch the first version of its AI Advocate tool, aimed at helping patients manage and guide their overall healthcare, in the third quarter of this year.

Today, 60% of all healthcare payments are in some form of value-based care if you include fee for service with quality metrics for upside bonuses, says Dave Snow, CEO of Cedar Gate Technologies.

The acquisition comes amid OpenEvidence's lawsuit alleging that Pathway Medical stole trade secrets, which Pathway has denied.

The company also disclosed that it reached an agreement with most holders of its Series A and Series B warrants to convert those warrants into common stock.

Data reveals that the people who are enrolling in Medicare Advantage have 50% more chronic conditions than people who are enrolling in Medicare fee-for-service, says Christie Teigland, Inovalon's VP of research science and advanced analytics.

The company began trading on the NYSE in May and saw an increase in its stock price upon the news of its second-quarter earnings.

The acquisition comes just months after Cerebral reached a settlement with the FTC over allegations of deceptive subscription and data-sharing practices.

A Silicon Valley Bank report reveals that healthcare sectors experienced strong growth in AI deal activity, especially in healthtech and biopharma.